Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases.

Autor: Wang X; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., You J; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Tang J; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Li X; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Wang R; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Li Y; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Bai Y; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China., Wang M; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China. wangmzh@lzu.edu.cn., Zheng S; Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China. zhengsh@lzu.edu.cn.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2024 Oct 14; Vol. 14 (1), pp. 24024. Date of Electronic Publication: 2024 Oct 14.
DOI: 10.1038/s41598-024-74841-3
Abstrakt: Backgrounds: This investigation seeks to explore the correlation between nonalcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVDs), and to to provide evidence for the prevention and treatment of CVDs.
Methods: This study utilized data from the Jinchang cohort platform, including 19,399 participants without pre-existing major CVDs. Based on the general population and gender stratification, Cox models were used to analyze the risk of NAFLD for CVDs. The combined effect of NAFLD and different obesity indicators on CVDs was analyzed by additive and multiplicative interaction models and subgroups.
Results: There were 3129 NAFLD patients out of 19399 subjects, and 723 (23.11%) of them had the CVD. After adjusting for multiple confounding factors, the Cox model revealed a 1.17-fold increase in the risk of CVDs among patients with NAFLD compared to those without NAFLD. Moreover, there was no notable disparity in CVDs risk among most NAFLD patients at the same level of obesity. The results indicated no additive interaction between NAFLD and obesity concerning CVDs risk, but rather a positive multiplicative interaction. Using the normal population as a reference, it was found that people with both obesity and NAFLD significantly increased the risk of developing CVDs, with HRs and 95% CIs of 1.790 (1.508, 2.126), 1.356 (1.213, 1.517), and 1.807 (1.503, 2.174), respectively, for BMI, WC, and the combination of BMI and WC.
Conclusions: NAFLD and obesity are independent risk factors for CVDs. The synergy of obesity and NAFLD implies that NAFLD patients should control weight gain. Larger BMI and WC values may increase the CVDs risk for NAFLD patients, especially women.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje